TXN(TXN)
TXN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $21.91B | $24.98B | $27.69B | $29.13B | $33.59B |
| Low | $20.48B | $23.06B | $24.56B | $27.12B | $31.28B |
| High | $22.43B | $26.37B | $35.53B | $32.57B | $37.56B |
| EBITDA Avg | $11.27B | $12.85B | $14.24B | $14.98B | $17.28B |
| Low | $10.54B | $11.86B | $12.63B | $13.95B | $16.09B |
| High | $11.54B | $13.56B | $18.27B | $16.75B | $19.32B |
| EBIT Avg | $9.58B | $10.92B | $12.11B | $12.74B | $14.69B |
| Low | $8.96B | $10.08B | $10.74B | $11.86B | $13.68B |
| High | $9.81B | $11.53B | $15.53B | $14.24B | $16.42B |
| Net Income Avg | $7.88B | $9.04B | $10.41B | $10.34B | $11.10B |
| Low | $6.54B | $8.11B | $9.24B | $9.41B | $10.11B |
| High | $8.34B | $10.44B | $16.84B | $11.92B | $12.81B |
| EPS Avg | $8.48 | $10.22 | $12.10 | $11.32 | $12.16 |
| Low | $7.16 | $8.88 | $10.12 | $10.31 | $11.07 |
| High | $9.14 | $11.44 | $18.44 | $13.06 | $14.03 |
| Analysts (Rev / EPS) | 23 / 20 | 25 / 22 | 25 / 18 | 12 / 9 | 12 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.92B | $5.73B | $5.78B | $6.19B | $6.58B | $6.34B | $6.63B | $7.02B |
| Low | $5.91B | $5.13B | $5.45B | $5.83B | $6.20B | $5.98B | $6.25B | $6.62B |
| High | $5.97B | $6.17B | $6.00B | $6.42B | $6.83B | $6.58B | $6.88B | $7.29B |
| EBITDA Avg | $3.04B | $2.95B | $2.97B | $3.18B | $3.39B | $3.26B | $3.41B | $3.61B |
| Low | $3.04B | $2.64B | $2.80B | $3.00B | $3.19B | $3.07B | $3.22B | $3.40B |
| High | $3.07B | $3.17B | $3.08B | $3.30B | $3.51B | $3.38B | $3.54B | $3.75B |
| EBIT Avg | $2.59B | $2.51B | $2.53B | $2.71B | $2.88B | $2.77B | $2.90B | $3.07B |
| Low | $2.58B | $2.24B | $2.38B | $2.55B | $2.71B | $2.61B | $2.73B | $2.89B |
| High | $2.61B | $2.70B | $2.62B | $2.81B | $2.99B | $2.88B | $3.01B | $3.19B |
| Net Income Avg | $2.22B | $2.10B | $2.11B | $2.33B | $2.56B | $2.40B | $2.60B | $2.84B |
| Low | $1.73B | $1.72B | $1.96B | $2.16B | $2.37B | $2.22B | $2.41B | $2.63B |
| High | $2.33B | $2.36B | $2.22B | $2.45B | $2.69B | $2.52B | $2.73B | $2.98B |
| EPS Avg | $2.42 | $2.29 | $2.30 | $2.54 | $2.78 | $2.61 | $2.83 | $3.09 |
| Low | $1.88 | $1.87 | $2.13 | $2.35 | $2.58 | $2.42 | $2.62 | $2.86 |
| High | $2.53 | $2.56 | $2.41 | $2.66 | $2.92 | $2.74 | $2.97 | $3.24 |
| Analysts (Rev / EPS) | 16 / 16 | 17 / 16 | 8 / 8 | 16 / 7 | 10 / 7 | 8 / 12 | 8 / 9 | 7 / 8 |